AcquisitionSvas Biosana strengthens its positioning in the distribution of medical devices to public healthcare institutions by acquiring 51% of Mehos Srl.
EarningsNet income reached €5.9m (+14.6% YoY), supported by effective cost control and easing raw material prices.
Financial PerformanceSvas Biosana delivered a solid 1Q 2025 with revenues of €32.7m (+14.3% YoY, +6.6% standalone), driven by recent acquisitions and strong momentum in the Balkans.